COMMUNIQUÉS West-GlobeNewswire

bioAffinity Technologies Announces Award of Canadian Patent
04/02/2019
SAN ANTONIO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies , a privately held biotech company, announced that the Canadian Intellectual Property Office has awarded a patent expanding the Company’s claims [...]
Cannabis Retailers: The Dawn of a New Industry
04/02/2019
VANCOUVER, British Columbia, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Mugglehead believes that Canadian cannabis retailers will be the next big focus for the industry. The current marijuana retail industry is practically non- [...]
Kiadis Pharma appoints Dr. Robert Friesen as Chief Scientific Officer
04/02/2019
Kiadis Pharma appoints Dr. Robert Friesen as Chief Scientific Officer Amsterdam, The Netherlands, and Boston, Massachusetts, USA - February 4, 2019 - Kiadis Pharma N.V. ("Kiadis" or the "Company") (Euronext Amsterdam [...]
New Hampshire Proposes Involuntary Servitude for Medical Professionals, States Association of American Physicians and Surgeons
04/02/2019
TUCSON, Ariz., Feb. 04, 2019 (GLOBE NEWSWIRE) -- New Hampshire has introduced legislation that essentially requires all licensed and actively practicing “health care practitioners and facilities” to accept as many [...]
New York Legalizes, Celebrates Defining Full-Term, Unborn Babies as Nonpersons, States Association of American Physicians and Surgeons
04/02/2019
TUCSON, Ariz., Feb. 04, 2019 (GLOBE NEWSWIRE) -- New York’s recently passed Reproductive Health Act states: “’Person,’ when referring to the victim of a homicide, means a human being who has been born and is alive” [...]
Virginia Governor Contradicts Oath of Hippocrates, States Association of American Physicians and Surgeons
04/02/2019
TUCSON, Ariz., Feb. 04, 2019 (GLOBE NEWSWIRE) -- In supporting abortion up to the moment of birth and even after, Virginia Governor Ralph Northam, M.D., a pediatric neurologist, has clearly renounced the Oath of [...]
Ossur Hf : Transactions in relation to share buyback program
04/02/2019
Announcement no. 06/2019 4 February 2019 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Ambu A/S: Allan Søgaard Larsen withdraws from Ambu's Board of Directors
04/02/2019
Allan Søgaard Larsen, who since 2011 has been a member of the Board in Ambu A/S, has for personal reasons decided to withdraw from the Board with immediate effect. Attachment Company_Announcement_no. 6 2018_19.pdf
Nivano Physicians, Inc. and Apollo Managed Care Together Supporting Provider Networks
04/02/2019
Integration of Apollo Managed Care Guidelines into Nivano Physicians’ workflow will place the required criteria for managing care at providers’ fingertips within its network – improving care coordination SACRAMENTO, [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 1 February 2019
04/02/2019
Bagsværd, Denmark, 4 February 2019 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article [...]
Tapping Into the Fastest Growing Segment in the Beverage Industry, Diamond CBD Announces the Arrival of New Brain Chill Slushy Machines
04/02/2019
Enabling Store Owners to Further Spread the Word About Cannabidiol Diamond CBD Brings Tasty CBD-Infused Frozen Drinks to Market FT LAUDERDALE, Fla., Feb. 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Diamond CBD Inc [...]
Pugliese Ciaccio First Hospital in Italy to Adopt Milestone Scientific’s CompuFlo® Instrument
04/02/2019
Real-time, objective tool for accurate epidural space identification boosts provider confidence LIVINGSTON, N.J., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) today announced Ospedale “ [...]
Data Published in the Journal of Parkinson’s Disease Demonstrate Real-World Clinical Benefit of Global Kinetics’ Personal KinetiGraph® in Optimizing Parkinson’s Disease Therapy
04/02/2019
- Additional monitoring data helped clinicians optimize drug therapy in nearly one-third of study patients - PORTSMOUTH, N.H. and LONDON and MELBOURNE, Australia and MOUNTAIN VIEW, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE [...]
BLVD Centers Changing Name to “Ventura Cannabis and Wellness Corp.” and Undertaking Share Consolidation
04/02/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED. LOS ANGELES, Feb. 04, 2019 (GLOBE NEWSWIRE) -- BLVD Centers [...]
Cannabis Beverages: 4 Stocks That Could Dominate the Space
04/02/2019
VANCOUVER, British Columbia, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Mugglehead believes the cannabis industry will look very different a year from now. By next year, edibles - including beverages - will likely be one of the [...]
SI-BONE, Inc. Announces Additional Exclusive Coverage Policies for iFuse
04/02/2019
Twenty-seven Blue Cross Blue Shield health care plans covering more than 50 million Americans now have positive “iFuse only” coverage policies for MIS SI joint fusion SANTA CLARA, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE [...]
Golden Leaf Holdings Appoints Karyn O. Barsa as Chief Financial Officer
04/02/2019
TORONTO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced the [...]
Ultragenyx Appoints Shehnaaz Suliman, M.D., to Board of Directors
04/02/2019
NOVATO, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Hemostemix Announces Submission of Orphan Drug Designation Application to the FDA
04/02/2019
CALGARY, Alberta, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: HMTXF) a biotechnology company focused on developing and commercializing innovative blood [...]

Pages